Number of the records: 1  

Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats

  1. 1.
    SYSNO ASEP0366961
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleEffect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats
    Author(s) Beneš, J. (CZ)
    Kazdová, L. (CZ)
    Drahota, Zdeněk (FGU-C) RID, ORCID
    Houštěk, Josef (FGU-C) RID, ORCID
    Medříková, Daša (FGU-C)
    Kopecký, Jan (FGU-C) RID, ORCID
    Kovářová, Nikola (FGU-C) RID
    Vrbacký, Marek (FGU-C) RID, ORCID
    Sedmera, David (FGU-C) RID, ORCID, SAI
    Strnad, Hynek (UMG-J) RID
    Kolář, Michal (UMG-J) RID, ORCID
    Petrák, J. (CZ)
    Benada, Oldřich (MBU-M) ORCID, RID
    Škaroupková, P. (CZ)
    Červenka, L. (CZ)
    Melenovský, V. (CZ)
    Source TitleClinical science. - : Portland Press - ISSN 0143-5221
    Roč. 121, č. 1 (2011), s. 29-41
    Number of pages13 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsAMP-activated protein kinase ; energy metabolism ; heart failure ; metformin ; survival ; volume overload
    Subject RIVFA - Cardiovascular Diseases incl. Cardiotharic Surgery
    R&D Projects1M0510 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    NS9757 GA MZd - Ministry of Health (MZ)
    1M0520 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z50110509 - FGU-C (2005-2011)
    AV0Z50520514 - UMG-J (2005-2011)
    AV0Z50200510 - MBU-M (2005-2011)
    UT WOS000293155200004
    DOI10.1042/CS20100527
    AnnotationThe present study examined whether metformin would improve cardiac function and survival also in non-diabetic heart failure of male Wistar rats. Metformin therapy normalized serum NEFAs, decreased myocardial glucose oxidation, increased myocardial palmitate oxidation, but it had no effect on myocardial gene expression, AMPK (AMP-activated protein kinase) signalling, ATP level, mitochondrial respiration, cardiac morphology, function and long-term survival, despite reaching therapeutic serum levels in rats with creating aortocaval fistula. In conclusion, metformin-induced enhancement of myocardial fatty acid oxidation had a neutral effect on cardiac function and survival. Reported cardioprotective effects of metformin may not be universal to all forms of heart failure and may require AMPK activation or ATP depletion. No increase in mortality on metformin supports its safe use in diabetic heart failure
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.